Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Endocrinology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Male Pattern Baldness Clinical Trials

A listing of Male Pattern Baldness medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (27) clinical trials

Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth

SAD part: A total of 3 weeks dosing, the two lowest concentrations in week 1, dose 3 at week 2 and finally dose 4 at week 3. MD part: In total 12 weeks of dosing where group A will be dosed twice weekly and group B three times weekly Each ...

Phase

TREg Activation in the Treatment of the PELADE (Alopecia Areata)

In a prospective pilot study the investigators showed that low doses of IL2 could be beneficial for severe AA inducing a long lasting regrowth in 4 out of the 5 patients treated. The objective of this study is to compare the long term efficacy of low doses of IL2 versus ...

Phase

Alopecia Areata Registry and Immunogenetic Mechanisms

The purpose of this registry is to collect patient epidemiology data as well as to provide samples that can be used for understanding the pathogenesis of AA, especially related to its genetic basis as a complex trait. There are three ways one can assess which genes are important: association studies ...

Phase N/A

Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain

Hair loss occurs commonly as a result of radiotherapy administered to the brain, and this can contribute to the distress and social isolation of patients with advanced cancer. In this study a topical gel will be applied directly to the scalp during each dose of radiotherapy. The goal is to ...

Phase

Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata

The aesthetic surgical & cosmetic discipline of hair restoration is rooted in numerous landmark studies and progressive medical science in the medical literature. With the advent of advanced theories and science using cellular and platelet-derived growth factors within the scope of regenerative medicine, have been well established in a number ...

Phase N/A

Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

This is a double-blind, randomized, placebo-controlled multi-center study consisting of 3 cohorts to assess the safety and efficacy of CTP-543. Each Cohort will be initiated sequentially in ascending dose order. Subjects will be randomized to either an active dose of CTP-543 or placebo for a 24-week treatment period.

Phase

A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

Primary To assess safety, tolerability and efficacy of 2 dose strengths of ATI-50002 Topical Solution, compared to vehicle in subjects with alopecia areata (AA) Secondary To evaluate key clinical outcome assessments

Phase

ENERGI-F701 for Female Hair Loss Treatment

The objective of this study is to evaluate the efficacy and safety of ENERGI-F701 Solution in female subjects with hair loss.

Phase

Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata

This is an open-label study which will be conducted at 1 to 2 sites. Subjects will be required to have a clinical diagnosis of AA, AU or AT with unilateral or bilateral loss of eyebrow hair. Subjects will apply study medication to the entire affected eyebrow(s), twice-daily for 24 weeks. ...

Phase

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata Alopecia Universalis or Alopecia Totalis

This Phase 2, multicenter, randomized study will evaluate the safety, tolerability and efficacy of ATI-501 for the treatment of AA, AU, or AT in adult subjects. Subjects will be required to have a clinical diagnosis of stable AA, AU, or AT. A total of 120 subjects will be randomized.

Phase